Scholarlink

Purpose <p>In pharmacology and clinical pharmacology (P&amp;CP) teaching, using generic names of medicines contributes to global comprehensibility. However, brand names are often used in routine clinical practice, which may pose a challenge in the educational setting. This study aimed to explore P&amp;CP teachers’ use of and attitudes towards generic and brand names in undergraduate education, as well as national prescription regulations.</p> Methods <p>A survey was conducted with P&amp;CP teachers from 38 European countries. An electronic questionnaire was used to collect data on the participants’ profiles, the nomenclature used and preferred in undergraduate education, and prescribing practices. The latter were then verified with national regulatory authorities.</p> Results <p>Sixty-one teachers from 23 countries participated in the study, the majority being physicians (<i>n</i> = 47). In total, 13 (21%) teachers use only generic names in their teaching, while 46 (75%) use both generic and brand names. Thirty-four (56%) teachers preferred listing brand names in case-based teaching, as this reflects real life. Conversely, 37 (61%) teachers stated that students should not be exposed to brand names before graduation. Generic prescribing is either allowed or mandatory in all participating countries except two, where brand-name prescribing is mandatory.</p> Conclusion <p>This study shows that generic names must remain fundamental in P&amp;CP education, but brand names also play a role, especially in case-based education, reflecting real-life practice. Potential implications of generic and brand prescribing for internationalisation in education could be worth further attention.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The use of generic versus brand names in (clinical) pharmacology education across Europe: a cross-sectional survey

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月10日

查看全文
  • Veronika Slezáková,
  • Jitka Rychlíčková,
  • Yoann Cazaubon,
  • Erik M. Donker,
  • Ellen van Leeuwen,
  • Robert Likic,
  • Dana Mazánková,
  • Joost D. Piët,
  • Fabrizio De Ponti,
  • Walter Raasch,
  • Floor van Rosse,
  • Emilio J. Sanz,
  • Markus Schwaninger,
  • Michiel A. van Agtmael,
  • Jelle Tichelaar

摘要

Purpose

In pharmacology and clinical pharmacology (P&CP) teaching, using generic names of medicines contributes to global comprehensibility. However, brand names are often used in routine clinical practice, which may pose a challenge in the educational setting. This study aimed to explore P&CP teachers’ use of and attitudes towards generic and brand names in undergraduate education, as well as national prescription regulations.

Methods

A survey was conducted with P&CP teachers from 38 European countries. An electronic questionnaire was used to collect data on the participants’ profiles, the nomenclature used and preferred in undergraduate education, and prescribing practices. The latter were then verified with national regulatory authorities.

Results

Sixty-one teachers from 23 countries participated in the study, the majority being physicians (n = 47). In total, 13 (21%) teachers use only generic names in their teaching, while 46 (75%) use both generic and brand names. Thirty-four (56%) teachers preferred listing brand names in case-based teaching, as this reflects real life. Conversely, 37 (61%) teachers stated that students should not be exposed to brand names before graduation. Generic prescribing is either allowed or mandatory in all participating countries except two, where brand-name prescribing is mandatory.

Conclusion

This study shows that generic names must remain fundamental in P&CP education, but brand names also play a role, especially in case-based education, reflecting real-life practice. Potential implications of generic and brand prescribing for internationalisation in education could be worth further attention.